PPARGC1A and diabetes mellitus: Various neurodegenerative diseases (eg, Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and Huntington's disease) demonstrate these molecular deregulations,112 whereas in diabetes, a decrease of PGC‐1α and NRF‐1 gene expression was found.113